Apotex Health Corp. (TSX:APTX)

Canada · Delayed Price · Currency is CAD

27.95

+0.93 (3.44%)

Jun 11, 2026, 3:55 PM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Conventional Generics	1.78B	1.87B	1.79B
Conventional Generics Growth	-4.90%	4.81%	-
Specialty Generics	1.15B	976.30M	784.21M
Specialty Generics Growth	17.94%	24.49%	-
Brands & Biosimilars	558.70M	500.96M	369.76M
Brands & Biosimilars Growth	11.53%	35.48%	-
Total	3.49B	3.35B	2.94B
Total Growth	4.21%	13.92%	-

Revenue by Geography

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Canada	1.43B	1.27B	1.08B
Canada Growth	12.88%	17.43%	-
United States (U.S.)	1.79B	1.81B	1.58B
United States (U.S.) Growth	-1.13%	14.69%	-
International	269.38M	271.05M	282.02M
International Growth	-0.62%	-3.89%	-
Total	3.49B	3.35B	2.94B
Total Growth	4.21%	13.92%	-

Source: S&P Global Market Intelligence.